Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 29.14% vs 18.77% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -72.99% vs -25.95% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "810.60",
          "val2": "627.70",
          "chgp": "29.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.20",
          "val2": "69.10",
          "chgp": "-75.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.40",
          "val2": "7.20",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.40",
          "val2": "27.40",
          "chgp": "-72.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.20%",
          "val2": "75.80%",
          "chgp": "-5.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.07% vs -0.63% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -179.14% vs -29.68% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,698.80",
          "val2": "2,140.70",
          "chgp": "26.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "114.50",
          "val2": "182.30",
          "chgp": "-37.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "32.80",
          "val2": "25.20",
          "chgp": "30.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-84.20",
          "val2": "106.40",
          "chgp": "-179.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.40%",
          "val2": "56.20%",
          "chgp": "-5.08%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

810.60

627.70

29.14%

Operating Profit (PBDIT) excl Other Income

17.20

69.10

-75.11%

Interest

8.40

7.20

16.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

7.40

27.40

-72.99%

Operating Profit Margin (Excl OI)

21.20%

75.80%

-5.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 29.14% vs 18.77% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -72.99% vs -25.95% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,698.80

2,140.70

26.07%

Operating Profit (PBDIT) excl Other Income

114.50

182.30

-37.19%

Interest

32.80

25.20

30.16%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-84.20

106.40

-179.14%

Operating Profit Margin (Excl OI)

5.40%

56.20%

-5.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 26.07% vs -0.63% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -179.14% vs -29.68% in Dec 2024

All Annual Results